Annual Revenue
$6.53 M
-$55.27 M-89.43%
December 31, 2023
Summary
- As of February 7, 2025, RDHL annual revenue is $6.53 million, with the most recent change of -$55.27 million (-89.43%) on December 31, 2023.
- During the last 3 years, RDHL annual revenue has fallen by -$57.83 million (-89.85%).
- RDHL annual revenue is now -92.39% below its all-time high of $85.76 million, reached on December 31, 2021.
Performance
RDHL Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
N/A
June 1, 2024
Summary
- RDHL quarterly revenue is not available.
Performance
RDHL Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
June 1, 2024
Summary
- RDHL TTM revenue is not available.
Performance
RDHL TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
RDHL Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -89.4% | - | - |
| 3 y3 years | -89.8% | - | - |
| 5 y5 years | -21.9% | - | - |
RDHL Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -92.4% | at low | ||||
| 5 y | 5-year | -92.4% | +3.8% | ||||
| alltime | all time | -92.4% | >+9999.0% |
RedHill Biopharma Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $6.53 M(-89.4%) | - | - |
| Jun 2023 | - | $1.80 M(-50.1%) | $35.74 M(-31.6%) |
| Mar 2023 | - | $3.60 M(-71.9%) | $52.30 M(-15.4%) |
| Dec 2022 | $61.80 M(-27.9%) | $12.80 M(-27.1%) | $61.80 M(-13.0%) |
| Sep 2022 | - | $17.55 M(-4.3%) | $71.07 M(-5.4%) |
| Jun 2022 | - | $18.35 M(+40.0%) | $75.13 M(-4.0%) |
| Mar 2022 | - | $13.10 M(-40.6%) | $78.29 M(-8.7%) |
| Dec 2021 | $85.76 M(+33.2%) | $22.07 M(+2.1%) | $85.76 M(+0.7%) |
| Sep 2021 | - | $21.61 M(+0.5%) | $85.15 M(+0.8%) |
| Jun 2021 | - | $21.50 M(+4.5%) | $84.48 M(+0.7%) |
| Mar 2021 | - | $20.57 M(-4.1%) | $83.88 M(+30.3%) |
| Dec 2020 | $64.36 M(+923.0%) | $21.46 M(+2.5%) | $64.36 M(+44.7%) |
| Sep 2020 | - | $20.94 M(+0.2%) | $44.49 M(+78.3%) |
| Jun 2020 | - | $20.90 M(+1879.1%) | $24.95 M(+344.7%) |
| Mar 2020 | - | $1.06 M(-33.6%) | $5.61 M(-10.8%) |
| Dec 2019 | $6.29 M(-24.7%) | $1.59 M(+13.5%) | $6.29 M(+3.8%) |
| Sep 2019 | - | $1.40 M(-10.4%) | $6.06 M(-11.7%) |
| Jun 2019 | - | $1.56 M(-10.0%) | $6.87 M(-10.3%) |
| Mar 2019 | - | $1.74 M(+27.8%) | $7.65 M(-8.5%) |
| Dec 2018 | $8.36 M(+108.6%) | $1.36 M(-38.4%) | $8.36 M(-7.1%) |
| Sep 2018 | - | $2.21 M(-6.1%) | $9.00 M(+8.2%) |
| Jun 2018 | - | $2.35 M(-3.9%) | $8.32 M(+28.9%) |
| Mar 2018 | - | $2.44 M(+22.2%) | $6.45 M(+61.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $4.01 M(+3867.3%) | $2.00 M(+31.4%) | $4.01 M(+90.3%) |
| Sep 2017 | - | $1.52 M(+215.3%) | $2.11 M(+261.2%) |
| Jun 2017 | - | $483.00 K(+383.0%) | $583.00 K(+477.2%) |
| Dec 2016 | $101.00 K(+3266.7%) | $100.00 K(+9900.0%) | $101.00 K(<-9900.0%) |
| Jun 2016 | - | $1000.00(-133.3%) | -$1000.00(<-9900.0%) |
| Dec 2015 | $3000.00(-100.0%) | -$3000.00(-400.0%) | $0.00(-100.0%) |
| Sep 2015 | - | $1000.00(0.0%) | $4000.00(-42.9%) |
| Jun 2015 | - | $1000.00(0.0%) | $7000.00(-30.0%) |
| Mar 2015 | - | $1000.00(0.0%) | $10.00 K(-99.9%) |
| Dec 2014 | $7.01 M(>+9900.0%) | $1000.00(-75.0%) | $7.01 M(0.0%) |
| Sep 2014 | - | $4000.00(0.0%) | $7.01 M(+0.0%) |
| Jun 2014 | - | $4000.00(-99.9%) | $7.01 M(0.0%) |
| Mar 2014 | - | $7.00 M(>+9900.0%) | $7.01 M(>+9900.0%) |
| Dec 2013 | $12.00 K(-25.0%) | $1000.00(-66.7%) | $12.00 K(-20.0%) |
| Sep 2013 | - | $3000.00(-25.0%) | $15.00 K(0.0%) |
| Jun 2013 | - | $4000.00(0.0%) | $15.00 K(-6.3%) |
| Mar 2013 | - | $4000.00(0.0%) | $16.00 K(0.0%) |
| Dec 2012 | $16.00 K(-30.4%) | $4000.00(+33.3%) | $16.00 K(+6.7%) |
| Sep 2012 | - | $3000.00(-40.0%) | $15.00 K(-34.8%) |
| Jun 2012 | - | $5000.00(+25.0%) | $23.00 K(+27.8%) |
| Mar 2012 | - | $4000.00(+33.3%) | $18.00 K(+28.6%) |
| Dec 2011 | $23.00 K | $3000.00(-72.7%) | $14.00 K(+27.3%) |
| Sep 2011 | - | $11.00 K | $11.00 K |
FAQ
- What is RedHill Biopharma annual revenue?
- What is the all time high annual revenue for RedHill Biopharma?
- What is RedHill Biopharma annual revenue year-on-year change?
- What is the all time high quarterly revenue for RedHill Biopharma?
- What is the all time high TTM revenue for RedHill Biopharma?
What is RedHill Biopharma annual revenue?
The current annual revenue of RDHL is $6.53 M
What is the all time high annual revenue for RedHill Biopharma?
RedHill Biopharma all-time high annual revenue is $85.76 M
What is RedHill Biopharma annual revenue year-on-year change?
Over the past year, RDHL annual revenue has changed by -$55.27 M (-89.43%)
What is the all time high quarterly revenue for RedHill Biopharma?
RedHill Biopharma all-time high quarterly revenue is $22.07 M
What is the all time high TTM revenue for RedHill Biopharma?
RedHill Biopharma all-time high TTM revenue is $85.76 M